Get started
Author

Érick Moyneur

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
2023 · Tanayott Thaweethai, Sarah E. Jolley, et al. · JAMA · 850
PDF
Population-based risk factors and resource utilization for HCC: US perspective
2010 · A. Sanyal, A. Poklepovic, et al. · Current Medical Research and Opinion · 312
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause
2016 · Fernand Labrie, David F. Archer, et al. · Menopause The Journal of The North American Menopause Society · 246
Risk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer
2005 · Matthew R. Smith, Simone Peart Boyce, et al. · The Journal of Urology · 213
The Relationship Between Technology Availability And Health Care Spending
2003 · Laurence Baker, Howard Birnbaum, et al. · Health Affairs · 155
Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause
2018 · Fernand Labrie, David F. Archer, et al. · Menopause The Journal of The North American Menopause Society · 114
Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy
2015 · Fernand Labrie, Leonard Derogatis, et al. · The Journal of Sexual Medicine · 91
Risk of Cancer Treatment—Associated Bone Loss and Fractures Among Women with Breast Cancer Receiving Aromatase Inhibitors
2006 · Betty A. Mincey, Mei Sheng Duh, et al. · Clinical Breast Cancer · 91
Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5 mg intravaginal prasterone for 12 weeks
2016 · Céline Martel, Fernand Labrie, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 72
Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study
2015 · Fernand Labrie, David F. Archer, et al. · Maturitas · 61
Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study
2015 · Céline Bouchard, Fernand Labrie, et al. · Hormone Molecular Biology and Clinical Investigation · 53
Multivariable confounding adjustment in distributed data networks without sharing of patient‐level data
2013 · Sengwee Toh, Marsha E. Reichman, et al. · Pharmacoepidemiology and Drug Safety · 35
Validity of Privacy-Protecting Analytical Methods That Use Only Aggregate-Level Information to Conduct Multivariable-Adjusted Analysis in Distributed Data Networks
2018 · Xiaojuan Li, Bruce H Fireman, et al. · American Journal of Epidemiology · 32
Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration
2015 · Yuyong Ke, Fernand Labrie, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 29
Prevalence of depression and anxiety in women newly diagnosed with vulvovaginal atrophy and dyspareunia
2019 · Erick Moyneur, Katherine Dea, et al. · Menopause The Journal of The North American Menopause Society · 28
Risk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer
2006 · Matthew R. Smith, Simone Peart Boyce, et al. · The Journal of Urology · 25
Real-World Evidence Comparing Vedolizumab and Ustekinumab in Antitumor Necrosis Factor-Experienced Patients With Crohn's Disease
2022 · Michael D. Kappelman, Sruthi Adimadhyam, et al. · The American Journal of Gastroenterology · 24
Combining distributed regression and propensity scores: a doubly privacy-protecting analytic method for multicenter research
2018 · Sengwee Toh, Robert Wellman, et al. · Clinical Epidemiology · 22
PDF
Costs associated with cardiovascular events in patients with hypertension in US managed care settings
2009 · Mei Sheng Duh, Nicole M. Fulcher, et al. · Journal of the American Society of Hypertension · 20
Identification-robust simulation-based inference in joint discrete/continuous models for energy markets
2007 · Denis Bolduc, Lynda Khalaf, et al. · Computational Statistics & Data Analysis · 19
Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner
2015 · F. Labrie, M. Montesino, et al. · Climacteric · 15
Privacy-protecting multivariable-adjusted distributed regression analysis for multi-center pediatric study
2019 · on behalf of the PCORnet Antibiotics and Childhood Growth Study Group, Sengwee Toh, et al. · Pediatric Research · 13
Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults
2024 · Yongkang Zhang, Alfonso Romieu-Hernandez, et al. · BMC Infectious Diseases · 12
PDF
Risk of Hypertension and Chronic Kidney Disease Following Aldosterone Dysregulation
2025 · Raymond R Townsend, Abiy Agiro, et al. · American Journal of Hypertension · 11
PDF
Prevalence of urinary tract infections in women with vulvovaginal atrophy and the impact of vaginal prasterone on the rate of urinary tract infections
2025 · Rachel Rubin, May Sanaee, et al. · Menopause The Journal of The North American Menopause Society · 11
Works count: 82
Citation count: 2,624
H-index: 19
I10-index: 27
Year
Topic
Type